MAB394-100
antibody from R&D Systems
Targeting: CCL18
AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18
Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB394-100 - Provider product page
- Provider
- R&D Systems
- Product name
- Human CCL18/PARC Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from ascites. Detects human CCL18/PARC in ELISAs and Western blots. In ELISAs, does not cross-react with recombinant human CCL3, 4, 14, 15, 23, recombinant mouse (rm) CCL3, rmCCL4, recombinant viral (rv) MIP-I or rvMIP-II.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antigen sequence
P55774.1
- Isotype
- IgG
- Antibody clone number
- 64507
- Vial size
- 100 ug
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.
Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis.
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer.
Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy.
Potential biomarkers of osteonecrosis in Gaucher disease.
The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria.
Brencicova E, Jagger AL, Evans HG, Georgouli M, Laios A, Attard Montalto S, Mehra G, Spencer J, Ahmed AA, Raju-Kankipati S, Taams LS, Diebold SS
PloS one 2017;12(4):e0175712
PloS one 2017;12(4):e0175712
Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis.
Quillinan N, Clark KE, Youl B, Vernes J, McIntosh D, Haq S, Denton CP
Arthritis research & therapy 2017 Mar 7;19(1):45
Arthritis research & therapy 2017 Mar 7;19(1):45
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer.
Su S, Liao J, Liu J, Huang D, He C, Chen F, Yang L, Wu W, Chen J, Lin L, Zeng Y, Ouyang N, Cui X, Yao H, Su F, Huang JD, Lieberman J, Liu Q, Song E
Cell research 2017 Apr;27(4):461-482
Cell research 2017 Apr;27(4):461-482
Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy.
Deegan PB, Pavlova E, Tindall J, Stein PE, Bearcroft P, Mehta A, Hughes D, Wraith JE, Cox TM
Medicine 2011 Jan;90(1):52-60
Medicine 2011 Jan;90(1):52-60
Potential biomarkers of osteonecrosis in Gaucher disease.
Pavlova EV, Deegan PB, Tindall J, McFarlane I, Mehta A, Hughes D, Wraith JE, Cox TM
Blood cells, molecules & diseases 2011 Jan 15;46(1):27-33
Blood cells, molecules & diseases 2011 Jan 15;46(1):27-33
The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria.
Bruna-Romero O, Schmieg J, Del Val M, Buschle M, Tsuji M
Journal of immunology (Baltimore, Md. : 1950) 2003 Mar 15;170(6):3195-203
Journal of immunology (Baltimore, Md. : 1950) 2003 Mar 15;170(6):3195-203
No comments: Submit comment
No validations: Submit validation data